{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:29:06Z","timestamp":1788535746866,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Solithromycin is a new macrolide-ketolide antibiotic with potential effectiveness in pediatric community-acquired bacterial pneumonia (CABP). Our objective was to evaluate its safety and effectiveness in children with CABP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This phase 2\/3, randomized, open-label, active-control, multicenter study randomly assigned solithromycin (capsules, suspension or intravenous) or an appropriate comparator antibiotic in a 3:1 ratio (planned n = 400) to children 2 months to 17 years of age with CABP. Primary safety endpoints included treatment-emergent adverse events (AEs) and AE-related drug discontinuations. Secondary effectiveness endpoints included clinical improvement following treatment without additional antimicrobial therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Unrelated to safety, the sponsor stopped the trial prior to completion. Before discontinuation, 97 participants were randomly assigned to solithromycin (n = 73) or comparator (n = 24). There were 24 participants (34%, 95% CI, 23%\u201347%) with a treatment-emergent AE in the solithromycin group and 7 (29%, 95% CI, 13%\u201351%) in the comparator group. Infusion site pain and elevated liver enzymes were the most common related AEs with solithromycin. Study drug was discontinued due to AEs in 3 subjects (4.3%) in the solithromycin group and 1 (4.2%) in the comparator group. Forty participants (65%, 95% CI, 51%\u201376%) in the solithromycin group achieved clinical improvement on the last day of treatment versus 17 (81%, 95% CI, 58%\u201395%) in the comparator group. The proportion achieving clinical cure was 60% (95% CI, 47%\u201372%) and 68% (95% CI, 43%\u201387%) for the solithromycin and comparator groups, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Intravenous and oral solithromycin were generally well-tolerated and associated with clinical improvement in the majority of participants treated for CABP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003559","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T17:00:52Z","timestamp":1650560452000},"page":"556-562","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9115-5312","authenticated-orcid":false,"given":"Jason E.","family":"Lang","sequence":"first","affiliation":[{"name":"Department of Pediatrics"},{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-8759","authenticated-orcid":false,"given":"Christoph P.","family":"Hornik","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Elliott","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2013-5087","authenticated-orcid":false,"given":"Adam","family":"Silverstein","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7656-3657","authenticated-orcid":false,"given":"Chi","family":"Hornik","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6532-7117","authenticated-orcid":false,"given":"Amira","family":"Al-Uzri","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Bosheva","sequence":"additional","affiliation":[{"name":"Medical University, Plovdiv, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Rady Children\u2019s Hospital, the University of California San Diego, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-7763","authenticated-orcid":false,"given":"Charissa Fay Corazon","family":"Borja-Tabora","sequence":"additional","affiliation":[{"name":"Research Institute for Tropical Medicine, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-0093","authenticated-orcid":false,"given":"David","family":"Di John","sequence":"additional","affiliation":[{"name":"Kirk Kerkorian School of Medicine at UNLV, Las Vegas, Nevada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mendez Echevarria","sequence":"additional","affiliation":[{"name":"Pediatric Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8765-2065","authenticated-orcid":false,"given":"Jessica E.","family":"Ericson","sequence":"additional","affiliation":[{"name":"Penn State College of Medicine, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-9082","authenticated-orcid":false,"given":"David","family":"Friedel","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University Medical Center, Richmond, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Gonczi","sequence":"additional","affiliation":[{"name":"University of Debrecen Clinical Center Infectology Clinic, Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Grace Dawn","family":"Isidro","sequence":"additional","affiliation":[{"name":"West Visayas State University Medical Center, Iloilo City, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura P.","family":"James","sequence":"additional","affiliation":[{"name":"Arkansas Children\u2019s Hospital Research Institute, Little Rock, Arkansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Kalocsai","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8396-9022","authenticated-orcid":false,"given":"Ioannis","family":"Koutroulis","sequence":"additional","affiliation":[{"name":"Children\u2019s National Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Laki","sequence":"additional","affiliation":[{"name":"Pulmonary Hospital, T\u00f6r\u00f6kb\u00e1lint, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-0167","authenticated-orcid":false,"given":"Anna Lisa T.","family":"Ong-Lim","sequence":"additional","affiliation":[{"name":"Philippine General Hospital, University of the Philippines Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Nad","sequence":"additional","affiliation":[{"name":"Kanizsai Dorottya Hospital, Nagykanizsa, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Simon","sequence":"additional","affiliation":[{"name":"Fej\u00e9r County Szent Gy\u00f6rgy University Teaching Hospital, Sz\u00e9kesfeh\u00e9rv\u00e1r, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3307-8379","authenticated-orcid":false,"given":"Salma","family":"Syed","sequence":"additional","affiliation":[{"name":"East Carolina University, Brody School of Medicine, Greenville, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9301-9015","authenticated-orcid":false,"given":"Eva","family":"Szabo","sequence":"additional","affiliation":[{"name":"Csolnoky Ferenc Hospital, Veszpr\u00e9m, Hungary."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-8585","authenticated-orcid":false,"given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2458-2266","authenticated-orcid":false,"given":"Michael","family":"Cohen-Wolkowiez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics"},{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the SOLI-PEDS Program","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"j686","DOI":"10.1136\/bmj.j686","article-title":"Community acquired pneumonia in children.","volume":"356","author":"Haq","year":"2017","journal-title":"BMJ"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/00006454-199811000-00004","article-title":"Etiology of childhood pneumonia: serologic results of a prospective, population-based study.","volume":"17","author":"Heiskanen-Kosma","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1086\/319981","article-title":"Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.","volume":"32","author":"Principi","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pcl.2008.10.005","article-title":"Pneumonia and other respiratory infections.","volume":"56","author":"Ranganathan","year":"2009","journal-title":"Pediatr Clin North Am"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1542\/pir.34.10.438","article-title":"Pneumonia.","volume":"34","author":"Gereige","year":"2013","journal-title":"Pediatr Rev"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/595857","article-title":"Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.","volume":"48","author":"Richter","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid1508.081187","article-title":"Increase in pneumococcus macrolide resistance, United States.","volume":"15","author":"Jenkins","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jiac.2017.12.010","article-title":"Laboratory surveillance of antimicrobial resistance and multidrug resistance among Streptococcus pneumoniae isolated in the Kinki region of Japan, 2001-2015.","volume":"24","author":"Toda","year":"2018","journal-title":"J Infect Chemother"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jiac.2018.09.003","article-title":"Antimicrobial activity of solithromycin and levofloxacin against a murine pneumonia mixed-infection model caused by Streptococcus pneumoniae and anaerobic bacteria.","volume":"25","author":"Kato","year":"2019","journal-title":"J Infect Chemother"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s40265-016-0667-z","article-title":"Solithromycin: a novel fluoroketolide for the treatment of community-acquired bacterial pneumonia.","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1128\/AAC.00582-08","article-title":"Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.","volume":"52","author":"Wolff","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/AAC.01123-09","article-title":"In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.","volume":"54","author":"McGhee","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jinf.2010.08.010","article-title":"The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009).","volume":"61","author":"Farrell","year":"2010","journal-title":"J Infect"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijantimicag.2010.01.026","article-title":"Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.","volume":"35","author":"Farrell","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2146\/ajhp160934","article-title":"Solithromycin: a novel ketolide antibiotic.","volume":"74","author":"Buege","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1473-3099(16)00017-7","article-title":"Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).","volume":"16","author":"Barrera","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/cid\/ciw490","article-title":"SOLITAIRE-IV: a randomized, double-blind, multicenter study comparing the efficacy and safety of intravenous-to-oral solithromycin to intravenous-to-oral moxifloxacin for treatment of community-acquired bacterial pneumonia.","volume":"63","author":"File","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"e00692","DOI":"10.1128\/AAC.00692-18","article-title":"Population pharmacokinetics and safety of solithromycin following intravenous and oral administration in infants, children, and adolescents.","volume":"62","author":"Gonzalez","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1128\/AAC.02561-15","article-title":"Solithromycin pharmacokinetics in plasma and dried blood spots and safety in adolescents.","volume":"60","author":"Gonzalez","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/INF.0b013e3180cbd2c7","article-title":"Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.","volume":"26","author":"Bradley","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00006454-199810000-00004","article-title":"Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.","volume":"17","author":"Harris","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/INF.0000000000001159","article-title":"A randomized, prospective study of pediatric patients with community-acquired pneumonia treated with ceftaroline versus ceftriaxone.","volume":"35","author":"Cannavino","year":"2016","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:08:49Z","timestamp":1749946129000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003559","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,7]]}}}